Volitionrx (VNRX) Net Cash Flow Growth (5y) (2016 - 2025)
Volitionrx (VNRX) Net Cash Flow Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.22 Bn | 6.27 Bn |
| 2 | Stryker | 128.20 Bn | 125.32 Bn | 3.81 Bn |
| 3 | Medtronic | 107.69 Bn | 98.47 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.05 Bn | 66.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.52 Bn | 43.85 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.17 Bn | 1.98 Bn |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.73 Bn | 26.15 Bn | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn |
| 10 | Volitionrx | 92,854.63 | -1.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.07% |
| Sep 30, 2025 | -81.02% |
| Jun 30, 2025 | -15.68% |
| Mar 31, 2025 | 34.71% |
| Dec 31, 2024 | -8.56% |
| Sep 30, 2024 | -37.00% |
| Jun 30, 2024 | -35.60% |
| Mar 31, 2024 | -38.38% |
| Dec 31, 2023 | 38.96% |
| Sep 30, 2023 | -32.09% |
| Jun 30, 2023 | 42.14% |
| Mar 31, 2023 | -17.00% |
| Dec 31, 2022 | -7.80% |
| Sep 30, 2022 | 30.78% |
| Jun 30, 2022 | -29.05% |
| Mar 31, 2022 | 24.54% |
| Dec 31, 2021 | -17.75% |
| Sep 30, 2021 | -20.08% |
| Jun 30, 2021 | -16.64% |
| Mar 31, 2021 | 4.13% |